Journal ID (nlm-ta): Br J Cancer
Journal ID (iso-abbrev): Br J Cancer
Title:
British Journal of Cancer
Publisher:
Nature Publishing Group UK
(London
)
ISSN
(Print):
0007-0920
ISSN
(Electronic):
1532-1827
Publication date
(Electronic):
3
May
2023
Publication date PMC-release: 3
May
2023
Publication date
(Print):
27
July
2023
Volume: 129
Issue: 1
Pages: 135-142
Affiliations
[1
]GRID grid.7143.1, ISNI 0000 0004 0512 5013, Department of Oncology, Vejle Hospital, , University Hospital of Southern Denmark, ; Beriderbakken 4, 7100 Vejle, Denmark
[2
]GRID grid.10825.3e, ISNI 0000 0001 0728 0170, Department of Regional Health Research, , University of Southern Denmark, ; J.B. Winsloews Vej 19, 3rd floor, 5000 Odense C, Denmark
[3
]GRID grid.7143.1, ISNI 0000 0004 0512 5013, Department of Biochemistry and Immunology, Vejle Hospital, , University Hospital of Southern Denmark, ; Beriderbakken 4, 7100 Vejle, Denmark
[4
]GRID grid.7143.1, ISNI 0000 0004 0512 5013, Department of Medicine, Vejle Hospital, , University Hospital of Southern Denmark, ; Beriderbakken 4, 7100 Vejle, Denmark
Author information
Article
Publisher ID:
2285
DOI: 10.1038/s41416-023-02285-z
PMC ID: 10307873
PubMed ID: 37137997
SO-VID: 37fbbbfd-7040-4d3a-a5d4-e18ddc2ad6e7
Copyright © © The Author(s) 2023
License:
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium
or format, as long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate if changes were
made. The images or other third party material in this article are included in the
article’s Creative Commons license, unless indicated otherwise in a credit line to
the material. If material is not included in the article’s Creative Commons license
and your intended use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright holder. To view
a copy of this license, visit
http://creativecommons.org/licenses/by/4.0/.
Funded by: Regional Strategic Council for Research in the Region of Southern Denmark, Dansk Kræftforskningsfond
(The Danish Foundation for Cancer Research), and the DCCC ctDNA Research Center -
The Danish Research Center for Circulating Tumor DNA Guided Cancer Management, Danish
Cancer Society (grant no. R257-A14700) and Danish Comprehensive Cancer Center. NK
Max provided the NK Vue kits free of charge.
Funded by: Regional Strategic Council for Research in the Region of Southern Denmark, Dansk Kræftforskningsfond
(The Danish Foundation for Cancer Research), and the DCCC ctDNA Research Center -
The Danish Research Center for Circulating Tumor DNA Guided Cancer Management, Danish
Cancer Society (grant no. R257-A14700) and Danish Comprehensive Cancer Center. NK
Max provided the NK Vue® kits free of charge.
Funded by: Regional Strategic Council for Research in the Region of Southern Denmark, Dansk Kræftforskningsfond
(The Danish Foundation for Cancer Research), and the DCCC ctDNA Research Center -
The Danish Research Center for Circulating Tumor DNA Guided Cancer Management, Danish
Cancer Society (grant no. R257-A14700) and Danish Comprehensive Cancer Center. NK
Max provided the NK Vue® kits free of charge.